Europe bets heavily on Pfizer in vaccine strategy overhaul

15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca ...

Read more →

Batch release assessment of COVID-19 vaccines

14 April 2021 - The Therapeutic Goods Administration ensures there is an independent quality assessment of every batch of vaccine supplied ...

Read more →

U.S. FDA to scrutinise vaccine design behind COVID-19 shots linked to blood clots

13 April 2021 - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood ...

Read more →

Atossa Therapeutics announces ovarian cancer patient has begun treatment with oral endoxifen under FDA’s Expanded Access Pathway

13 April 2021 - Atossa Therapeutics today announced that an ovarian cancer patient has begun treatment with Atossa’s proprietary oral endoxifen.  ...

Read more →

New recommendations on the critical appraisal of systematic reviews with cost and cost effectiveness outcomes

13 April 2021 - ISPOR announced today the publication of new guidance on how to evaluate the quality and risk ...

Read more →

Did Australia get it right on AstraZeneca?

14 April 2021 - The almost-total absence of criticism for Australia’s decision to preference Pfizer’s vaccine over AstraZeneca’s for people ...

Read more →

National cabinet to return to 'war footing' in effort to fix problem-plagued COVID vaccine rollout

13 April 2021 - Prime Minister Scott Morrison has asked the National Cabinet to hold two meetings a week to try ...

Read more →

Scotland opens door to Translarna for Duchenne muscular dystrophy

13 April 2021 - A disparity in UK access to a medicine for Duchenne muscular dystrophy has been addressed, after ...

Read more →

Qilian International announces inclusion of 16 products into China's National Reimbursement Drugs List

13 April 2021 - Qilian International today announced that 16 of its products have been included in the latest version of ...

Read more →

Europe tries to lower drug prices with small doses of transparency

13 April 2021 - For countries in Europe, negotiating a deal with a pharma company over drug prices is the ...

Read more →

Four medicines accepted for use by NHS Scotland

13 April 2021 - The Scottish Medicines Consortium has approved NHS funding for four new medicines, including treatments for multiple ...

Read more →

FDA grants accelerated approval to sacituzumab govitecan for advanced urothelial cancer

13 April 2021 - Today the Food and Drug Administration granted accelerated approval to sacituzumab govitecan (Trodelvy, Immunomedics) for patients ...

Read more →

vTv Therapeutics receives FDA breakthrough therapy designation for TTP399 for the treatment of type 1 diabetes

13 April 2021 - Designation offers potential for expedited development pathway and reinforces TTP399’s potential to provide a substantial clinical benefit. ...

Read more →

Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine

13 April 2021 - The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation ...

Read more →

Avenue Therapeutics announces that the FDA is still reviewing its NDA resubmission for IV tramadol

13 April 2021 - The FDA has not provided a decision regarding the new drug application. ...

Read more →

Adamis Pharmaceuticals provides an update on Zimhi

12 April 2021 - Adamis Pharmaceuticals today provided an update on the status of the company’s new drug application relating ...

Read more →